Air quality statement issued for Calgary: ECCC
An air quality statement was issued for Calgary Sunday morning.
An air quality statement was issued for Calgary Sunday morning as wildfire smoke rolled into the region.
Environment and Climate Change Canada (ECCC) posted on its website at 8:06 a.m. that 'wildfire smoke is causing poor air quality and reduced visibility in some areas."
It said that conditions were expected to improve later in the day Sunday.
The air quality index Sunday at 9:23 a.m. was 7, or 'high-risk.'
For more information about wildfire smoke and its impact on your health, go here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
22 minutes ago
- CTV News
Combined fire now approximately seven times the size of Winnipeg: province
Fire WE017 near Sherridon, Man. on May 27, 2025. (Submitted: Manitoba government) Two wildfires that have combined are now approximately seven times the size of Winnipeg, according to the provincial government. Fire WE017, located near Sherridon, Man., was reported on Sunday to be about 307,781 hectares and out-of-control — the largest in the province. A provincial spokesperson confirmed that the previously numbered fire WE024 — which was reported to be nearly 38,000 hectares near Flin Flon on June 4 — has combined with fire WE017. As of June 5, the province began reporting the collective size of both fires. The fire has placed several communities under a mandatory evacuation. Meanwhile, the provincial government said in a media release that fire EA061 is approximately five times the size of Winnipeg. The fire is approximately 203,720 hectares and out-of-control, stretching from Bird River to Bissett, Man. The Manitoba Wildfire Service continues to respond to 28 active wildfires in Manitoba, according to the media release.
CBC
26 minutes ago
- CBC
Drizzle in northern Manitoba not enough to quench wildfires as community leaders hope for downpour
Social Sharing As evacuees fleeing wildfires in northern Manitoba watched rain fall in parts of the province on Sunday, community leaders are warning the north needs heavier downpour to help firefighters on the ground. Lori Forbes, emergency co-ordinator for the Rural Municipality of Kelsey, said Sunday's rain didn't fall where it was needed most. "We did get the rain in The Pas but we need the rain in the north. We need the rain where the fires are to help the firefighters," Forbes said. She said The Pas was about 100 kilometres away from the fire on Sunday afternoon. According to the province's most recent fire bulletin on Sunday, the wildfire near Sherridon is more than 300,000 hectares in size and is still out of control. "The further north you went, the less rain there was," Forbes said. The eight-degree temperatures are helping fire crews, she said, but it's windy and the weather is "changing very quickly." Flin Flon Mayor George Fontaine said he has been staying with his son in Winnipeg since the northern Manitoba city was evacuated nearly two weeks ago. Fontaine told CBC News that Saturday was a cooler day with calmer winds, allowing crews to wet down areas near the town and put out some hot spots. However, the weather and fire behaviour has been unpredictable, he said. "I don't know that we can say what's going to happen, but I'm hoping for rain, I'll tell you that," Fontaine said from Winnipeg, as a heavy downpour was hitting the pavement just before 4 p.m. CT. "Well, if they got there, what we're getting here today, that would be a lovely thing," he said. Sheryl Matheson, Sherridon's deputy mayor and president of Northern Association of Community Councils, said there was light rain in the area that caused a lot of smoke. "It wasn't a significant amount of rain that was coming down. It needs to turn into more of a downpour," she said. She said the drizzle has been keeping the ground wet, but it isn't enough to help crews battling the fire. "We're praying for a downpour," Matheson said.
Globe and Mail
32 minutes ago
- Globe and Mail
Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock?
Many companies have failed to disrupt the complicated U.S. healthcare market. Hims & Hers (NYSE: HIMS) may finally be succeeding in cracking the code. The online telehealth platform focuses on circumventing the insurance market; its business of selling affordable medications directly to individuals is growing like a weed, and expects to generate $6.5 billion in revenue by 2030. It has had a tumultuous start to 2025, as Hims & Hers waged a battle to sell new weight loss medications on its online marketplace. Now, with momentum back on its side, the stock is up 118% year to date and 446% in the last five years. Let's take a deeper look at this company, and see whether you might want to buy Hims & Hers stock for your portfolio now. Disrupting the healthcare market Hims & Hers' model is simple. It has two separate web platforms -- Hims for men and Hers for women -- that sell medications and deliver to customers' front doors. It began with sexual health, but has moved into dermatology, hair loss, mental health, and now weight loss medications. A key to its success has been avoiding the insurance market with products that don't break the bank. Customers loathe dealing with health insurers in the United States, and sometimes would rather not use insurance at all. Plus, some of these products aren't covered by insurance. This strategy has helped the company close in on over $2 billion in projected revenue in 2025. To keep up this impressive growth, Hims & Hers wants to offer weight loss medications, which have been a blockbuster set of drugs for the pharmaceutical market. For a while the popularity of these drugs, such as Novo Nordisk 's Wegovy, left them in short supply; that allowed third parties such as Hims & Hers to produce them as a compounding pharmacy and sell them at much cheaper prices. This ended up generating $200 million of Hims & Hers' $1.4 billion in 2024 revenue. But with the shortage of Wegovy over and the compounding pharmacy exception ended, the company's weight-loss business was at a major turning point. Luckily, at the end of April Hims & Hers announced a partnership with Novo Nordisk that seems to resolve this issue: It gives Hims & Hers the ability to sell Wegovy directly on its platform. Hims & Hers is not an exclusive supplier of the drug -- or any drugs on its marketplaces, to be fair -- but it hopes to use its subscription business model, marketing expertise, and simplified user proposition to drive sales for Novo Nordisk in the huge obesity-care market. Going abroad and personalization Besides weight loss drugs, Hims & Hers has more ambitions to reach its goal of $6.5 billion in revenue by 2030. Just recently, the company announced its intent to acquire European competitor Zava so it could expand its telehealth service to Europe. The acquisition will add a platform with 1.3 million active customers in the U.K., Germany, France, and Ireland. It makes sense that Hims & Hers can supercharge growth for the platform with its plethora of medications offered to customers, keen marketing skills, and subscription-based selling model. Over the long run, Hims & Hers aims to make healthcare for its customers more personalized. This includes unique drug combinations, its own outsourcing facility, and at-home testing capabilities. Details remain sparse, but the vision is clear: disrupting more and more of the trillions of dollars spent on healthcare by building a business that people actually enjoy interacting with. This is why 2.4 million active customers use Hims & Hers today. HIMS Gross Profit Margin data by YCharts. Should you buy Hims & Hers stock? A revenue goal of $6.5 billion seems well within reach by 2030. Hims & Hers is only at 2.4 million active customers, and there are tens of millions of people in the United States alone who could start using or switch to one of its telehealth platforms. Add on the Zava acquisition in Europe, and the runway for growth gets even larger. The company has an impressive gross profit margin of 77%, which should lead to high levels of profitability at scale. On $6.5 billion in future revenue, it could very well post a net profit margin of over 20%, and achieve $1.5 billion in bottom-line profits and free cash flow. A 20% profit margin is easily achievable because of its high gross margins and the fact it currently spends 40% of revenue on marketing today, a figure that has come down over time and should come down even more as Hims & Hers keeps scaling. However, Hims & Hers has played fast and loose with laws and regulations in the past. It sold weight loss drugs when the legality of doing so was unclear, and although that dispute seems to have been resolved, management could easily start playing with fire again and burn its reputation as a trusted provider of medications. Otherwise, this looks like a fantastic growth stock that just doubled its addressable market with the Zava acquisition. Today, Hims & Hers has a market cap of $12.3 billion. You might think it's overvalued because of the stock's recent run-up in price, but the numbers show that patient investors could be rewarded by holding for the long term. A $12.3 billion market cap is only around 8 times my 2030 earnings estimate of $1.5 billion, which would be a dirt cheap price-to-earnings (P/E) ratio for a fast-growing company compared to the current market cap. Most likely, the stock will be valued at a higher multiple than 8, meaning that the stock will be higher in five years. It doesn't come without risks, but if you're a growth investor, you might love Hims & Hers stock for its long-term potential. Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor 's total average return is792% — a market-crushing outperformance compared to173%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025
